Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report)’s share price rose 28.6% during trading on Monday . The company traded as high as C$0.21 and last traded at C$0.18. Approximately 1,188,155 shares traded hands during mid-day trading, an increase of 253% from the average daily volume of 336,778 shares. The stock had previously closed at C$0.14.
Voyageur Pharmaceuticals Stock Performance
The business has a fifty day moving average of C$0.08 and a 200-day moving average of C$0.06. The company has a debt-to-equity ratio of 3.21, a quick ratio of 0.84 and a current ratio of 0.17. The company has a market capitalization of C$18.83 million, a P/E ratio of -13.50 and a beta of 0.32.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Further Reading
- Five stocks we like better than Voyageur Pharmaceuticals
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- 4 Social Media Stocks Set to Gain as TikTok Ban Looms
- Do ETFs Pay Dividends? What You Need to Know
- How Do Stock Buybacks Affect Shareholders?
- Investing in the High PE Growth Stocks
- JPMorgan Chase & Co. Stock Can Hit $300 This Year
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
